Bactigram

Cefaclor

Bactigram

Active substance

Cefaclor

Strenght and pharmaceutical forms

250 mg/5 ml granules for oral suspension –100ml bottle
500 mg hard capsules – 8 hard capsules
750 mg modified release tablets – 6 tablets

ATC

J01DC04; Antibiotic for oral use, belonging to the class of cephalosporins

Therapeutic Indications

SUSPENSION and CAPSULES

Cefaclor is indicated for the treatment of the following infections sustained by susceptible germs:

Respiratory tract infections, including pneumonia, bronchitis, exacerbations of chronic bronchitis, pharyngitis and tonsillitis;
otitis media;
skin and soft tissue infections;
urinary tract infections, including pyelonephritis and cystitis;
sinusitis;
gonococcal urethritis.
TABLETS 750 mg

It is indicated for the treatment of the most serious forms of the following infections:

acute bronchitis and exacerbation of chronic bronchitis;
pharyngitis and tonsillitis;
skin and soft tissue infections;
uncomplicated infections of the lower urinary tract.

Marketing Authorization Holder

Magis Farmaceutici S.r.l.

null

Download area

Summary of Product Characteristics - granules and hard capsules

Summary of Product Characteristics - released modified tablets


Products of the same therapeutic areas

Events

13-14/09/2019

SCLEROTHERAPY & VENOUS ABLATION

Pisa Palazzo dei Congressi

Primo congresso intersocietario Associazione Flebologica Italiana, Società Italiana FleboLinfologica, Società Italiana di Flebologia Clinica e Sperimentale

 Download

14-16/06/2019

33° Congresso Nazionale della Società Italiana per lo Studio delle Cefalee

Napoli

Congresso Nazionale della Società Italiana per lo Studio delle Cefalee